Replies to post #544971 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for the reply.

I believe that this is such a relevant topic— the evolution of the FDA in recent recent years toward RWE and immunotherapy/cell-based science has been a relatively rapid change. It’s fascinating and exciting to research this topic!






https://www.fda.gov/drugs/news-events-human-drugs/50-years-progress-treating-patients-cancer

https://www.fda.gov/about-fda/fda-organization/oncology-center-excellence

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug

https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847